Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression.

Mohamed BA, Hartmann N, Tirilomis P, Sekeres K, Li W, Neef S, Richter C, Zeisberg EM, Kattner L, Didié M, Guan K, Schmitto JD, Lehnart SE, Luther S, Voigt N, Seidler T, Sossalla S, Hasenfuss G, Toischer K.

Sci Transl Med. 2018 Sep 12;10(458). pii: eaan0724. doi: 10.1126/scitranslmed.aan0724.

PMID:
30209242
2.

Driving After Left Ventricular Assist Device Implantation.

Hanke JS, Riebandt J, Wahabzada M, Nur F, Wahabzada A, Dogan G, Feldmann C, Haverich A, Popov AF, Zimpfer D, Schmitto JD.

Artif Organs. 2018 Jul;42(7):695-699. doi: 10.1111/aor.13130.

PMID:
30117586
3.

Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.

Schmitto JD, Pya Y, Zimpfer D, Krabatsch T, Garbade J, Rao V, Morshuis M, Beyersdorf F, Marasco S, Sood P, Damme L, Netuka I.

Eur J Heart Fail. 2018 Jul 27. doi: 10.1002/ejhf.1284. [Epub ahead of print]

PMID:
30052304
4.

Successful HeartMate 3 implantation in isolated right heart failure-first in man experience of right heart configuration.

Ricklefs M, Hanke JS, Dogan G, Chatterjee A, Feldmann C, Deniz E, Korte W, Kirchhoff F, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1834-S1837. doi: 10.21037/jtd.2018.05.35. No abstract available.

5.

How to do it: tips and tricks of minimal-invasive HVAD® implantation-the lateral approach.

Deniz E, Chatterjee A, Feldmann C, Hanke JS, Dogan G, Berliner D, Shrestha ML, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1829-S1833. doi: 10.21037/jtd.2018.05.149. No abstract available.

6.

A new tool for an explantation strategy of HeartMate 3™ left ventricular assist device.

Ricklefs M, Deodhar C, Chatterjee A, Feldmann C, Hanke JS, Heimeshoff J, Merz C, Deniz E, Dogan G, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1825-S1828. doi: 10.21037/jtd.2018.04.57.

7.

Telemonitoring of left-ventricular assist device patients-current status and future challenges.

Reiss N, Schmidt T, Boeckelmann M, Schulte-Eistrup S, Hoffmann JD, Feldmann C, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1794-S1801. doi: 10.21037/jtd.2018.01.158. Review.

8.

The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD).

Chatterjee A, Feldmann C, Hanke JS, Ricklefs M, Shrestha M, Dogan G, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1790-S1793. doi: 10.21037/jtd.2017.10.124. Review.

9.

Clinical overview of the HVAD: a centrifugal continuous-flow ventricular assist device with magnetic and hydrodynamic bearings including lateral implantation strategies.

Chatterjee A, Feldmann C, Dogan G, Hanke JS, Ricklefs M, Deniz E, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1785-S1789. doi: 10.21037/jtd.2018.04.148. Review.

10.

Clinical care for patients with recurrent myocardial ischemia in Germany-the VOICES trial.

Berliner D, Maier LS, Wollenberg U, Limberg R, Schmitto JD, Westermann D, Bauersachs J.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1777-S1784. doi: 10.21037/jtd.2017.10.123.

11.

MitraClip procedure prior to left ventricular assist device implantation.

Dogan G, Hanke JS, Ricklefs M, Chatterjee A, Feldmann C, Mashaqi B, Deniz E, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1763-S1768. doi: 10.21037/jtd.2018.05.36.

12.

Successful establishment of a left ventricular assist device program in an emerging country: one year experience.

Nestorovic E, Schmitto JD, Kushwaha SS, Putnik S, Terzic D, Milic N, Mikic A, Markovic D, Trifunovic D, Ristic A, Ristic M.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1743-S1750. doi: 10.21037/jtd.2018.04.147.

13.

The influence of less invasive ventricular assist device implantation on renal function.

Ricklefs M, Heimeshoff J, Hanke JS, Chatterjee A, Dogan G, Shrestha M, Feldmann C, Wert L, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1737-S1742. doi: 10.21037/jtd.2017.10.03.

14.

Left ventricular assist device exchange for the treatment of HeartMate II pump thrombosis.

Hanke JS, Dogan G, Wert L, Ricklefs M, Heimeshoff J, Chatterjee A, Feldmann C, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1728-S1736. doi: 10.21037/jtd.2018.01.115.

15.

Argatroban administration as therapy for thrombosis in patients with continuous-flow ventricular assist devices.

Wert L, Hanke JS, Dogan G, Ricklefs M, Chatterjee A, Feldmann C, Ismail I, Napp LC, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1720-S1727. doi: 10.21037/jtd.2017.10.164.

16.

An acoustic method for systematic ventricular assist device thrombus evaluation with a novel artificial thrombus model.

Feldmann C, Deniz E, Stomps A, Knigge S, Chatterjee A, Wendl R, Hanke JS, Dogan G, Napp LC, Glasmacher B, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1711-S1719. doi: 10.21037/jtd.2018.04.11.

17.

Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices-5-year follow-up.

Wert L, Hanke JS, Dogan G, Ricklefs M, Fleißner F, Chatterjee A, Feldmann C, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1703-S1710. doi: 10.21037/jtd.2018.03.127.

18.

Minimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock.

Wert L, Chatterjee A, Dogan G, Hanke JS, Boethig D, Tümler KA, Napp LC, Berliner D, Feldmann C, Kuehn C, Martens A, Shrestha ML, Haverich A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1696-S1702. doi: 10.21037/jtd.2018.01.27.

19.

Less invasive HeartMate 3 left ventricular assist device implantation.

Schmitto JD, Krabatsch T, Damme L, Netuka I.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1692-S1695. doi: 10.21037/jtd.2018.01.26.

20.

The evolution of mechanical circulatory support (MCS): a new wave of developments in MCS and heart failure treatment.

Chatterjee A, Schmitto JD.

J Thorac Dis. 2018 Jun;10(Suppl 15):S1688-S1691. doi: 10.21037/jtd.2018.05.205. No abstract available.

21.

In vitro study for the evaluation of transluminal aspiration as a novel treatment option for thrombosis in the HeartWare HVAD.

Gärtner T, Beropoulis E, Wendl R, Hanke JS, Dogan G, Chatterjee A, Haverich A, Torsello G, Schmitto JD, Bisdas T, Feldmann C.

Int J Artif Organs. 2018 Jul 1:391398818785557. doi: 10.1177/0391398818785557. [Epub ahead of print]

PMID:
30019601
22.

Rupture of the Free Left Ventricular Wall: A Novel Approach for Reconstruction.

Fleißner F, Schmitto JD, Napp C, Ismail I.

Thorac Cardiovasc Surg Rep. 2018 Jan;7(1):e30-e32. doi: 10.1055/s-0038-1642613. Epub 2018 Jun 28.

23.

Hemoadsorption in cardiac shock with bi ventricular failure and giant-cell myocarditis: A case report.

Dogan G, Hanke J, Puntigam J, Haverich A, Schmitto JD.

Int J Artif Organs. 2018 Aug;41(8):474-479. doi: 10.1177/0391398818777362. Epub 2018 May 30.

PMID:
29843541
24.

The clinical impact of donor-specific antibodies in heart transplantation.

Barten MJ, Schulz U, Beiras-Fernandez A, Berchtold-Herz M, Boeken U, Garbade J, Hirt S, Richter M, Ruhpawar A, Sandhaus T, Schmitto JD, Schönrath F, Schramm R, Schweiger M, Wilhelm M, Zuckermann A.

Transplant Rev (Orlando). 2018 May 8. pii: S0955-470X(17)30114-3. doi: 10.1016/j.trre.2018.05.002. [Epub ahead of print] Review.

PMID:
29804793
25.

Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.

Sieweke JT, Pfeffer TJ, Berliner D, König T, Hallbaum M, Napp LC, Tongers J, Kühn C, Schmitto JD, Hilfiker-Kleiner D, Schäfer A, Bauersachs J.

Eur Heart J Acute Cardiovasc Care. 2018 May 1:2048872618777876. doi: 10.1177/2048872618777876. [Epub ahead of print]

PMID:
29792513
26.

A Review of Induction with Rabbit Antithymocyte Globulin in Pediatric Heart Transplant Recipients.

Schweiger M, Zuckermann A, Beiras-Fernandez A, Berchtolld-Herz M, Boeken U, Garbade J, Hirt S, Richter M, Ruhpawar A, Schmitto JD, Schönrath F, Schramm R, Schulz U, Wilhelm MJ, Barten MJ.

Ann Transplant. 2018 May 15;23:322-333. doi: 10.12659/AOT.908243.

27.

Treatment of Ventricular Assist Device Thrombus by Implantation of an Additional Left Ventricular Assist Device.

Ricklefs M, Hanke JS, Schmitto JD.

Artif Organs. 2018 Apr;42(4):464-465. doi: 10.1111/aor.13015. No abstract available.

PMID:
29667249
28.

Left Ventricular Assist Devices - A State of the Art Review.

Feldmann C, Chatterjee A, Haverich A, Schmitto JD.

Adv Exp Med Biol. 2018;1067:287-294. doi: 10.1007/5584_2018_145.

PMID:
29532330
29.

One-year outcomes with the HeartMate 3 left ventricular assist device.

Hanke JS, Dogan G, Zoch A, Ricklefs M, Wert L, Feldmann C, Bara C, Shrestha M, Tillmanns J, Kempf T, Bauersachs J, Haverich A, Schmitto JD.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):662-669. doi: 10.1016/j.jtcvs.2018.01.083. Epub 2018 Feb 13.

PMID:
29525258
30.

Treatment of an Intercostal Left Ventricular Assist Device Prolapse by Upgrading From HeartMate II to HeartMate 3.

Wert L, Hanke JS, Rojas SV, Dogan G, Feldmann C, Rodt T, Haverich A, Schmitto JD.

Artif Organs. 2018 Feb;42(2):242-244. doi: 10.1111/aor.12981. No abstract available.

PMID:
29436023
31.

Less Invasive Surgical Approaches for Left Ventricular Assist Device Implantation.

Ricklefs M, Hanke JS, Dogan G, Napp LC, Feldmann C, Haverich A, Schmitto JD.

Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):1-6. doi: 10.1053/j.semtcvs.2018.01.002. Epub 2018 Jan 31.

PMID:
29366876
32.

Inert gas rebreathing - helpful tool in the management of left ventricular assist device patients.

Reiss N, Schmidt T, Mommertz S, Feldmann C, Schmitto JD.

Perfusion. 2018 Jul;33(5):335-338. doi: 10.1177/0267659117751621. Epub 2018 Jan 4.

PMID:
29301460
33.

The short- and long-term risks of venoarterial extracorporeal membrane oxygenation watershed.

Napp LC, Schmitto JD, Tongers J, Schäfer A.

Eur J Cardiothorac Surg. 2018 Apr 1;53(4):894. doi: 10.1093/ejcts/ezx375. No abstract available.

PMID:
29126219
34.

Single-centre experience with the frozen elephant trunk technique in 251 patients over 15 years.

Shrestha M, Martens A, Kaufeld T, Beckmann E, Bertele S, Krueger H, Neuser J, Fleissner F, Ius F, Abd Alhadi F, Hanke J, Schmitto JD, Cebotari S, Karck M, Haverich A, Chavan A.

Eur J Cardiothorac Surg. 2017 Nov 1;52(5):858-866. doi: 10.1093/ejcts/ezx218.

PMID:
28977379
35.

First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus.

Hanke JS, Rojas SV, Cvitkovic T, Wiegmann B, Horke A, Warnecke G, Haverich A, Schmitto JD.

Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):503-508. doi: 10.1093/icvts/ivx124.

PMID:
28962493
36.

Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE-HF) study.

Lund LH, Trochu JN, Meyns B, Caliskan K, Shaw S, Schmitto JD, Schibilsky D, Damme L, Heatley J, Gustafsson F.

Eur J Heart Fail. 2018 Jan;20(1):152-160. doi: 10.1002/ejhf.975. Epub 2017 Sep 27.

PMID:
28960673
37.

Five-year results of patients supported by HeartMate II: outcomes and adverse events.

Hanke JS, Rojas SV, Mahr C, Schmidt AF, Zoch A, Dogan G, Feldmann C, Deniz E, Molitoris U, Bara C, Strüber M, Haverich A, Schmitto JD.

Eur J Cardiothorac Surg. 2017 Sep 2. doi: 10.1093/ejcts/ezx313. [Epub ahead of print]

PMID:
28958073
38.

First Implantation of a Novel Left Ventricular Assist Device: The ReliantHeart aVAD.

Schmitto JD, Hanke JS, Dogan G, Tessmann R, Jeevanandem V, Cohn WE, Frazier OH, Haverich A.

Ann Thorac Surg. 2017 Oct;104(4):e311-e313. doi: 10.1016/j.athoracsur.2017.04.049.

PMID:
28935323
39.

Valve-sparing David I procedure in acute aortic type A dissection: a 20-year experience with more than 100 patients.

Beckmann E, Martens A, Pertz J, Kaufeld T, Umminger J, Hanke JS, Schmitto JD, Cebotari S, Haverich A, Shrestha ML.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):319-324. doi: 10.1093/ejcts/ezx170.

PMID:
28838101
40.

Novel centrifugal pump for heart failure patients: initial success and future challenges.

Feldmann C, Chatterjee A, Hanke JS, Dogan G, Haverich A, Schmitto JD.

J Thorac Dis. 2017 Jun;9(6):1429-1431. doi: 10.21037/jtd.2017.05.68. No abstract available.

41.

Venoarterial Extracorporeal Membrane Oxygenation: Lower Speed, and You May Be Faster.

Napp LC, Tongers J, Schmitto JD, Schäfer A.

Ann Thorac Surg. 2017 Aug;104(2):724-725. doi: 10.1016/j.athoracsur.2016.10.050. No abstract available.

PMID:
28734422
42.

Left Ventricular Assist Device Therapy for Destination Therapy: Is Less Invasive Surgery a Safe Alternative?

Rojas SV, Hanke JS, Avsar M, Ahrens PR, Deutschmann O, Tümler KA, Uribarri A, Rojas-Hernández S, Sánchez PL, González-Santos JM, Haverich A, Schmitto JD.

Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):13-17. doi: 10.1016/j.rec.2017.03.023. Epub 2017 Jun 20. English, Spanish.

PMID:
28645834
43.

Telemonitoring and Medical Care of Heart Failure Patients Supported by Left Ventricular Assist Devices - The Medolution Project.

Reiss N, Schmidt T, Müller-von Aschwege F, Thronicke W, Hoffmann JD, Röbesaat JI, Deniz E, Hein A, Krumm H, Stewing FJ, Willemsen D, Schmitto JD, Feldmann C.

Stud Health Technol Inform. 2017;236:267-274.

PMID:
28508806
44.

Adaptive Pump Speed Algorithms to Improve Exercise Capacity in Patients Supported with a Left-Ventricular Assist Device.

Schmidt T, Reiss N, Deniz E, Feldmann C, Hein A, Hoffmann JD, Röbesaat JI, Schmitto JD, Willemsen D, Müller-von Aschwege F.

Stud Health Technol Inform. 2017;236:235-240.

PMID:
28508801
45.

Electric smog: telemetry interference between ICD and LVAD.

Duncker D, König T, Müller-Leisse J, Michalski R, Oswald H, Schmitto JD, Bauersachs J, Veltmann C.

Herzschrittmacherther Elektrophysiol. 2017 Sep;28(3):257-259. doi: 10.1007/s00399-017-0509-z. Epub 2017 May 12. Review.

PMID:
28500612
46.

Left Ventricular Assist Devices for Advanced Heart Failure.

Schmitto JD, Rojas SV, Haverich A.

N Engl J Med. 2017 May 11;376(19):1894. doi: 10.1056/NEJMc1703374. No abstract available.

PMID:
28489990
47.

Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure -1 year results from the Ce mark trial.

Krabatsch T, Netuka I, Schmitto JD, Zimpfer D, Garbade J, Rao V, Morshuis M, Beyersdorf F, Marasco S, Damme L, Pya Y.

J Cardiothorac Surg. 2017 Apr 4;12(1):23. doi: 10.1186/s13019-017-0587-3.

48.

First series of left ventricular assist device exchanges to HeartMate 3.

Hanke JS, Rojas SV, Dogan G, Feldmann C, Beckmann E, Deniz E, Wiegmann B, Michaelis JE, Napp LC, Berliner D, Shrestha M, Bauersachs J, Haverich A, Schmitto JD.

Eur J Cardiothorac Surg. 2017 May 1;51(5):887-892. doi: 10.1093/ejcts/ezx010.

PMID:
28329060
49.

First experiences with HeartMate 3 follow-up and adverse events.

Hanke JS, Dogan G, Rojas SV, Zoch A, Feldmann C, Deniz E, Avsar M, Warnecke G, Haverich A, Schmitto JD.

J Thorac Cardiovasc Surg. 2017 Jul;154(1):173-178. doi: 10.1016/j.jtcvs.2017.01.045. Epub 2017 Feb 9.

PMID:
28268010
50.

Exchange of a HeartWare HVAD to a HeartMate 3 left ventricular assist device.

Hanke JS, Haverich A, Schmitto JD.

J Heart Lung Transplant. 2017 Apr;36(4):480-481. doi: 10.1016/j.healun.2016.12.005. Epub 2016 Dec 23. No abstract available.

PMID:
28089426

Supplemental Content

Loading ...
Support Center